TetraLogic Pharmaceuticals Valuation
| TLOG Stock | USD 0.0001 0.00 0.00% |
TetraLogic Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of TetraLogic Pharmaceuticals from inspecting the company fundamentals such as Return On Asset of -0.2, shares owned by institutions of 0.01 %, and Price To Earning of (0.03) X as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that TetraLogic Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of TetraLogic Pharmaceuticals is based on 3 months time horizon. Increasing TetraLogic Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the TetraLogic pink sheet is determined by what a typical buyer is willing to pay for full or partial control of TetraLogic Pharmaceuticals Corp. Since TetraLogic Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TetraLogic Pink Sheet. However, TetraLogic Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The real value of TetraLogic Pink Sheet, also known as its intrinsic value, is the underlying worth of TetraLogic Pharmaceuticals Company, which is reflected in its stock price. It is based on TetraLogic Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of TetraLogic Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of TetraLogic Pharmaceuticals Corp helps investors to forecast how TetraLogic pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TetraLogic Pharmaceuticals more accurately as focusing exclusively on TetraLogic Pharmaceuticals' fundamentals will not take into account other important factors: About TetraLogic Pharmaceuticals Valuation
The pink sheet valuation mechanism determines TetraLogic Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of TetraLogic Pharmaceuticals. We calculate exposure to TetraLogic Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of TetraLogic Pharmaceuticals's related companies.TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Tetralogic Pharmaceu operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 29 people.
8 Steps to conduct TetraLogic Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates TetraLogic Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct TetraLogic Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain TetraLogic Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine TetraLogic Pharmaceuticals' revenue streams: Identify TetraLogic Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research TetraLogic Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish TetraLogic Pharmaceuticals' growth potential: Evaluate TetraLogic Pharmaceuticals' management, business model, and growth potential.
- Determine TetraLogic Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate TetraLogic Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
TetraLogic Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as TetraLogic Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 23.7 M | |
| Retained Earnings | -175.6 M |
Complementary Tools for TetraLogic Pink Sheet analysis
When running TetraLogic Pharmaceuticals' price analysis, check to measure TetraLogic Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TetraLogic Pharmaceuticals is operating at the current time. Most of TetraLogic Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of TetraLogic Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TetraLogic Pharmaceuticals' price. Additionally, you may evaluate how the addition of TetraLogic Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |